Ensysce Biosciences Inc
ENSC
Loading quote...
Financials
| 52Week High | 14.67 | 52Week Low | 1.62 |
| Beta | 1.05 | Current Ratio Annual | 2.42 |
| Current Ratio Quarterly | 2.50 | Market Cap | 4.88M |
| Net Profit Margin TTM | -109.51 | Operating Margin TTM | -110.13 |
| Price To Book | 1.60 | Price To Sales TTM | 0.78 |
| Quick Ratio Annual | 1.65 | Quick Ratio Quarterly | 1.87 |
| Return On Assets TTM | -121.77 | Return On Equity TTM | -176.20 |
| Return On Investment TTM | -161.57 | Revenue Growth3Y | 13.86 |
| Revenue Growth Quarterly Yoy | 331.69 | Revenue Growth TTMYoy | 255.51 |
| Revenue Per Share TTM | 4.44 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 9 | 1 | 2 | 0 | 0 | 0 | 140.82K | $1.12M |
| Mar 31, 2025 | 9 | 2(+100%) | 2 | 4(+%) | 0 | 2(+%) | 350.15K(+149%) | $896.39K(-20%) |
| Jun 30, 2025 | 11(+22%) | 3(+50%) | 2 | 2(-50%) | 1(+%) | 3(+50%) | 178.78K(-49%) | $391.98K(-56%) |